<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04745663</url>
  </required_header>
  <id_info>
    <org_study_id>SW2019-3</org_study_id>
    <secondary_id>2019-001179-35</secondary_id>
    <nct_id>NCT04745663</nct_id>
  </id_info>
  <brief_title>Optimizing Preoperative Disinfection of Eyes</brief_title>
  <official_title>Optimizing Preoperative Disinfection of Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Topical povidone-iodine (PI) is widely used as ocular antiseptic before and after surgery.&#xD;
      The standard dose of 5% PI is however, associated with ocular irritation. We therefore want&#xD;
      to test if a lower concentration of PI can be similarly efficacious in reducing bacterial&#xD;
      growth while reducing ocular irritation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Not the expected 2/3 but only 1/3 of conjunctiva samples got bacterial growth. Lack of&#xD;
    resources to keep the study going with more participants and over a considerably longer time&#xD;
    than anticipated.&#xD;
  </why_stopped>
  <start_date type="Actual">February 8, 2021</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Both eyes of the participants are tested; one eye randomised to receive the intervention and the second eye to receive the standard disinfection.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Conjunctival bacterial culture</measure>
    <time_frame>1 hour. Bacterial sample is taken before and immediately after disinfection</time_frame>
    <description>Change in colony-forming units (CFU) per milliliter (ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient pain score</measure>
    <time_frame>During disinfection and after 1 hour when the anesthetic no longer is effective</time_frame>
    <description>Verbal numeric rating scale, from 0 to 10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ocular staining score (OSS)</measure>
    <time_frame>1 hour after disinfection</time_frame>
    <description>Modified OSS using fluorescein dye</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Eye Infections</condition>
  <arm_group>
    <arm_group_label>Povidone-Iodine 0.3 %</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A tampon is soaked in diluted PI 0.3% and placed on the inside of the lower eyelid of one eye, where it will release iodine molecules for 20 minutes before being removed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Povidone-Iodine 5 %</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eye drops of 5% PI is the standard disinfection before eye surgery. The drops will be dripped in one eye and allowed to work for 2 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Povidone-Iodine 0.3%</intervention_name>
    <description>Low concentration iodine</description>
    <arm_group_label>Povidone-Iodine 0.3 %</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Povidone-Iodine 5%</intervention_name>
    <description>Standard concentration iodine</description>
    <arm_group_label>Povidone-Iodine 5 %</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients remitted to intravitreal injections at St. Olavs hospital.&#xD;
&#xD;
          -  Patients competent to give written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Infectious disease&#xD;
&#xD;
          -  Known epitheliopathy&#xD;
&#xD;
          -  Contact lens wear&#xD;
&#xD;
          -  Use of prescription ophthalmic medications&#xD;
&#xD;
          -  Diabetes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorunn Helbostad, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marit Fagerli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinic of Ear-Nose-Throat, Eye and Maxillofacial Surgery, St. Olavs Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Disinfection</keyword>
  <keyword>Pre-operative</keyword>
  <keyword>Povidone Iodine</keyword>
  <keyword>Eye surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Cadexomer iodine</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

